NeuroRx
Research ServicesQuebec, Canada51-200 Employees
NeuroRx is a Montreal-based provider of imaging-focused services for pharmaceutical clinical trials, with a focus on multiple sclerosis and other neurological diseases. It manages all MRI-related study activities and delivers precise, regulatory-compliant MRI outcome measurements to support decision-making in trials. The company also offers specialized logistics for scan handling and tracking, and can provide exclusive MRI services if required. Using advanced image analysis, NeuroRx yields outcome data that capture both lesion-related and non-lesional pathology, including brain atrophy, with 3D analyses that relate findings to broader brain structures. In March 2025, NeuroRx was acquired by Clario Holdings Inc, reflecting a notable development in the clinical-trial imaging analytics space.